220 related articles for article (PubMed ID: 30937914)
1. Canadian expert consensus: management of hypersensitivity reactions to intravenous iron in adults.
Lim W; Afif W; Knowles S; Lim G; Lin Y; Mothersill C; Nistor I; Rehman F; Song C; Xenodemetropoulos T
Vox Sang; 2019 May; 114(4):363-373. PubMed ID: 30937914
[TBL] [Abstract][Full Text] [Related]
2. Prevention and management of acute reactions to intravenous iron in surgical patients.
Gómez-Ramírez S; Shander A; Spahn DR; Auerbach M; Liumbruno GM; Vaglio S; Muñoz M
Blood Transfus; 2019 Mar; 17(2):137-145. PubMed ID: 30418128
[TBL] [Abstract][Full Text] [Related]
3. Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management.
Rampton D; Folkersen J; Fishbane S; Hedenus M; Howaldt S; Locatelli F; Patni S; Szebeni J; Weiss G
Haematologica; 2014 Nov; 99(11):1671-6. PubMed ID: 25420283
[TBL] [Abstract][Full Text] [Related]
4. [Hypersensitivity reactions to intravenous iron: an allergist' perspective].
Moi L; Stehlin F; Desseauve D; Ribi C; Muller YD
Rev Med Suisse; 2022 Apr; 18(776):639-645. PubMed ID: 35385614
[TBL] [Abstract][Full Text] [Related]
5. Hypersensitivity reactions and deaths associated with intravenous iron preparations.
Bailie GR; Clark JA; Lane CE; Lane PL
Nephrol Dial Transplant; 2005 Jul; 20(7):1443-9. PubMed ID: 15855210
[TBL] [Abstract][Full Text] [Related]
6. Expert consensus guidelines: Intravenous iron uses, formulations, administration, and management of reactions.
Van Doren L; Steinheiser M; Boykin K; Taylor KJ; Menendez M; Auerbach M
Am J Hematol; 2024 Jul; 99(7):1338-1348. PubMed ID: 38282557
[TBL] [Abstract][Full Text] [Related]
7. Approach to hypersensitivity reactions from intravenous iron preparations.
Morales Mateluna CA; Scherer Hofmeier K; Bircher AJ
Allergy; 2017 May; 72(5):827-830. PubMed ID: 27977865
[TBL] [Abstract][Full Text] [Related]
8. Hypersensitivity to intravenous iron: classification, terminology, mechanisms and management.
Szebeni J; Fishbane S; Hedenus M; Howaldt S; Locatelli F; Patni S; Rampton D; Weiss G; Folkersen J
Br J Pharmacol; 2015 Nov; 172(21):5025-36. PubMed ID: 26265306
[TBL] [Abstract][Full Text] [Related]
9. Safety in iron management.
Fishbane S
Am J Kidney Dis; 2003 Jun; 41(5 Suppl):18-26. PubMed ID: 12776310
[TBL] [Abstract][Full Text] [Related]
10. Anaphylactoid reactions to methotrexate.
Alkins SA; Byrd JC; Morgan SK; Ward FT; Weiss RB
Cancer; 1996 May; 77(10):2123-6. PubMed ID: 8640680
[TBL] [Abstract][Full Text] [Related]
11. Intravenous iron dextran in clinical medicine.
Hamstra RD; Block MH; Schocket AL
JAMA; 1980 May; 243(17):1726-31. PubMed ID: 6154155
[TBL] [Abstract][Full Text] [Related]
12. Association between in-line filtration and Type I hypersensitivity reactions in pediatric oncology patients receiving intravenous etoposide.
Ronsley R; Jacques L; Potts JE; Clement K; Dix DB; Mahon P
Pediatr Hematol Oncol; 2021 Apr; 38(3):208-215. PubMed ID: 33150845
[TBL] [Abstract][Full Text] [Related]
13. Anaphylaxis to intravenous cyclosporine and tolerance to oral cyclosporine: case report and review.
Volcheck GW; Van Dellen RG
Ann Allergy Asthma Immunol; 1998 Feb; 80(2):159-63. PubMed ID: 9494448
[TBL] [Abstract][Full Text] [Related]
14. Continuous administration of intravenous iron during haemodialysis.
Granolleras C; Zein A; Oulès R; Branger B; Fourcade J; Shaldon S
Nephrol Dial Transplant; 1997 May; 12(5):1007-8. PubMed ID: 9175059
[TBL] [Abstract][Full Text] [Related]
15. Benchmarking iron dextran sensitivity: reactions requiring resuscitative medication in incident and prevalent patients.
Walters BA; Van Wyck DB
Nephrol Dial Transplant; 2005 Jul; 20(7):1438-42. PubMed ID: 15840683
[TBL] [Abstract][Full Text] [Related]
16. Intravenous Iron Therapy: Re-administration after Prior Adverse Reaction.
Aung T; Thein H; Aung ST; Soe BTA; Ohnmar E
Korean J Fam Med; 2023 Nov; 44(6):350-354. PubMed ID: 37599005
[TBL] [Abstract][Full Text] [Related]
17. Safety of intravenous iron use in chronic kidney disease.
Kalra PA; Bhandari S
Curr Opin Nephrol Hypertens; 2016 Nov; 25(6):529-535. PubMed ID: 27557350
[TBL] [Abstract][Full Text] [Related]
18. Practical Guidelines for Perioperative Hypersensitivity Reactions.
Laguna JJ; Archilla J; Doña I; Corominas M; Gastaminza G; Mayorga C; Berjes-Gimeno P; Tornero P; Martin S; Planas A; Moreno E; Torres MJ
J Investig Allergol Clin Immunol; 2018; 28(4):216-232. PubMed ID: 29411702
[TBL] [Abstract][Full Text] [Related]
19. Best practices in multiple sclerosis: infusion reactions versus hypersensitivity associated with biologic therapies.
Namey M; Halper J; O'leary S; Beavin J; Bishop C
J Infus Nurs; 2010; 33(2):98-111. PubMed ID: 20228647
[TBL] [Abstract][Full Text] [Related]
20. Iron management in chronic kidney disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
Macdougall IC; Bircher AJ; Eckardt KU; Obrador GT; Pollock CA; Stenvinkel P; Swinkels DW; Wanner C; Weiss G; Chertow GM;
Kidney Int; 2016 Jan; 89(1):28-39. PubMed ID: 26759045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
